Andrew Jones is the Chief Financial Officer at Eyenovia, Inc., an ophthalmic pharmaceutical technology company with two FDA-approved products.
Andrew Jones is the Chief Financial Officer at Eyenovia, Inc., an ophthalmic pharmaceutical technology company with two FDA-approved products and a late-stage asset. Prior to joining Eyenovia in September 2024, he served as CFO and Treasurer of NovaBay Pharmaceuticals, a publicly traded ophthalmic company. Jones has over 30 years of finance and accounting leadership experience in therapeutics and medical technology/devices, and previously held a Vice President of Finance role at MyoScience, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library